| Deployment and Clinical Evaluation of an AI-powered Digital Oncology Biomarker Tool to guidE Treatment in TNBC (NCT06396754) | Institute of Cancer Research, United Kingdom | 2026-08-01 |
| Investigating the Combination of Bexmarilimab and Nivolumab in Solid Tumours, Melanoma and NSCLC (NCT07718243) | Institute of Cancer Research, United Kingdom | 2026-08-01 |
| The BALANCE Study: BlAck and Mixed Men's Lived Experience With Prostate cANCEr-Diversity in Prostate Cancer PROMS Study (NCT07529418) | Institute of Cancer Research, United Kingdom | 2026-05-05 |
| 5G-PEARL: Paxalisib in Malignant Brain Tumours (NCT07391215) | Institute of Cancer Research, United Kingdom | 2026-01-19 |
| The eValuation of Sources of vIBRAtioN for Vibrational Shear Wave elasTography (NCT07098819) | Institute of Cancer Research, United Kingdom | 2025-09-01 |
| Investigating Idetrexed and Olaparib in Patients With Ovarian Cancer (NCT06976892) | Institute of Cancer Research, United Kingdom | 2025-08-01 |
| The i4i PRODICT® Study: Evaluation of the i4i PRODICT® Test in Different Ethnic Groups (The i4i PRODICT® Study). (NCT06636526) | Institute of Cancer Research, United Kingdom | 2025-06-02 |
| Investigating SX-682 in Combination With Apalutamide in Metastatic Castration-resistant Prostate Cancer (NCT07002320) | Institute of Cancer Research, United Kingdom | 2025-04-28 |
| 5G-RUBY: Avutometinib and Defactinib in Malignant Brain Tumours (NCT06630260) | Institute of Cancer Research, United Kingdom | 2024-11-15 |
| 5G-EMERALD: Amivantamab in Malignant Brain Tumours (NCT06632236) | Institute of Cancer Research, United Kingdom | 2024-10-09 |
| The COherence of Scatter Identification and Exclusion Algorithm Study (NCT06975579) | Institute of Cancer Research, United Kingdom | 2024-08-27 |
| SBRT Alone or Followed by Niraparib for Oligometastases or Oligoprogression in Ovarian Cancer Following PARPi Therapy (NCT05990192) | Institute of Cancer Research, United Kingdom | 2024-06-20 |
| Combination Study of Antibiotics With Enzalutamide (PROMIZE) (NCT06126731) | Institute of Cancer Research, United Kingdom | 2023-11-02 |
| Microbiome Molecular Charaterisation (NCT06423976) | Institute of Cancer Research, United Kingdom | 2023-10-23 |
| The Active Surveillance Study (NCT05810467) | Institute of Cancer Research, United Kingdom | 2023-08-22 |
| POTENT - Tepotinib in Combination With Pembrolizumab in NSCLC (NCT05782361) | Institute of Cancer Research, United Kingdom | 2023-05-03 |
| A Trial of 5 Fraction Prostate SBRT Versus 5 Fraction Prostate and Pelvic Nodal SBRT (NCT05613023) | Institute of Cancer Research, United Kingdom | 2022-09-09 |
| ASTEROID: A Trial of ASTX660 in Combination With Pembrolizumab (NCT05082259) | Institute of Cancer Research, United Kingdom | 2022-03-02 |
| Hypofractionated Expedited Radiotherapy for Men With localisEd proState Cancer (NCT04595019) | Institute of Cancer Research, United Kingdom | 2021-07-29 |
| Digital Delivery of Information About Genetic Testing for Breast Cancer (NCT04842799) | Institute of Cancer Research, United Kingdom | 2021-07-05 |
| Understanding the Genetic and Biological Factors That Influence Cancer Treatment Response and Resistance in Patients With Advanced Solid Tumours Through Sample Analysis (NCT07737509) | Institute of Cancer Research, United Kingdom | 2021-04-28 |
| CORONADO (Circulating tumOur pROtein quaNtification cApillary blooD cOvid-19) (NCT04659252) | Institute of Cancer Research, United Kingdom | 2021-03-04 |
| PreOperative Endocrine Therapy for Individualised Care With Abemaciclib (NCT04584853) | Institute of Cancer Research, United Kingdom | 2020-12-23 |
| Abiraterone Acetate in Combination With Tildrakizumab (NCT04458311) | Institute of Cancer Research, United Kingdom | 2020-12-01 |
| Exploring the Mechanisms and Dynamics of Clonal Evolution Leading to Recurrence in Prostate Cancer (NCT04686188) | Institute of Cancer Research, United Kingdom | 2020-11-26 |
| Myeloma Novel Drug Discovery Ver 1.2 (NCT05968417) | Institute of Cancer Research, United Kingdom | 2020-07-22 |
| KORTUC Phase II - Intra-tumoural Radiation Sensitizer in Patients With Locally Advanced/Recurrent Breast Cancer (NCT03946202) | Institute of Cancer Research, United Kingdom | 2020-06-16 |
| Molecular Stratification Profiling Protocol in Metastatic Castration Resistant Prostate Cancer (mCRPC) - MAESTRO (NCT03934164) | Institute of Cancer Research, United Kingdom | 2019-11-28 |
| ATr Inhibitor in Combination With Olaparib/Durvalumab (MEDI4736) in Gynaecological Cancers With ARId1A Loss or no Loss (NCT04065269) | Institute of Cancer Research, United Kingdom | 2019-11-27 |
| PHOENIX DDR/Anti-PD-L1 Trial: A Pre-surgical Window of Opportunity and Post-surgical Adjuvant Biomarker Study of DNA Damage Response Inhibition With or Without Anti-PD-L1 Immunotherapy in Patients With Neoadjuvant Treatment Resistant Residual Triple Negative Breast Cancer (NCT03740893) | Institute of Cancer Research, United Kingdom | 2019-10-15 |
| Exploring the Link Between Cancer Genetics and PPSP (NCT04007861) | Institute of Cancer Research, United Kingdom | 2019-07-01 |
| Transcriptional Responses as an Indicator of Individualised Responses to Radiation Effects (RTGene 2) (NCT03809377) | Institute of Cancer Research, United Kingdom | 2019-05-09 |
| The BARCODE 1 Study (Full Study): The Use of Genetic Profiling to Guide Prostate Cancer Targeted Screening. (NCT03857477) | Institute of Cancer Research, United Kingdom | 2019-03-14 |
| Precision Medicine in the Prostate Cancer Care Pathway (NCT04763317) | Institute of Cancer Research, United Kingdom | 2019-02-14 |
| Prospective Evaluation of Radiotherapy Using Magnetic Resonance Image Guided Treatment (NCT03727698) | Institute of Cancer Research, United Kingdom | 2019-01-11 |
| Trial of Pembrolizumab in Metastatic Castration Resistant Prostate Cancer (NCT03506997) | Institute of Cancer Research, United Kingdom | 2018-11-27 |
| The eValuation of Image Guidance of Stereotactic Body Radiotherapy Using Ultrasound: Assessment in Liver (NCT03592550) | Institute of Cancer Research, United Kingdom | 2018-09-01 |
| A Trial of Ipatasertib in Combination With Atezolizumab (NCT03673787) | Institute of Cancer Research, United Kingdom | 2018-08-13 |
| Magnetic Resonance Guided High Intensity Focused Ultrasound (MRgHIFU) for Pain Palliation of Bone Metastases (NCT03479151) | Institute of Cancer Research, United Kingdom | 2018-03-16 |
| PUMA (Paediatric Osseous Marrow Assessment) (NCT03466944) | Institute of Cancer Research, United Kingdom | 2018-03-05 |
| The Role of Hypoxia as a Selective Pressure for TP53 Mutations (NCT03466034) | Institute of Cancer Research, United Kingdom | 2018-02-06 |
| A Trial Using ctDNA Blood Tests to Detect Cancer Cells After Standard Treatment to Trigger Additional Treatment in Early Stage Triple Negative Breast Cancer Patients (NCT03145961) | Institute of Cancer Research, United Kingdom | 2017-12-21 |
| Phase I Trial of Defactinib and VS-6766. (NCT03875820) | Institute of Cancer Research, United Kingdom | 2017-12-12 |
| Stereotactic Body Radiotherapy for the Treatment of OPD (NCT03256981) | Institute of Cancer Research, United Kingdom | 2017-11-27 |
| Combination Study of AZD5069 and Enzalutamide. (NCT03177187) | Institute of Cancer Research, United Kingdom | 2017-11-13 |
| Pimo Study: Extracellular Vesicle-based Liquid Biopsy to Detect Hypoxia in Tumours (NCT03262311) | Institute of Cancer Research, United Kingdom | 2017-11-10 |
| PRIMER: Development of Daily Online Magnetic Resonance Imaging for Magnetic Resonance Image Guided Radiotherapy (NCT02973828) | Institute of Cancer Research, United Kingdom | 2017-10-17 |
| The BARCODE 2 Study - The Use of Genetic Profiling to Guide Prostate Cancer Treatment (NCT02955082) | Institute of Cancer Research, United Kingdom | 2017-05-25 |
| International Penile Advanced Cancer Trial (International Rare Cancers Initiative Study) (NCT02305654) | Institute of Cancer Research, United Kingdom | 2017-05-12 |
| KORTUC: Intra-tumoural Hydrogen Peroxide as a Radiation Sensitizer in Patients With Locally Advanced/Recurrent Breast Cancer in Terms of Toxicity and Tumour Response (NCT02757651) | Institute of Cancer Research, United Kingdom | 2017-01-19 |
| Utilising CTC Counts to Optimize Systemic Therapy of Metastatic Prostate Cancer (NCT03327662) | Institute of Cancer Research, United Kingdom | 2017-01-11 |
| The UK Plasma Based Molecular Profiling of Advanced Breast Cancer to Inform Therapeutic CHoices (plasmaMATCH) Trial (NCT03182634) | Institute of Cancer Research, United Kingdom | 2016-12-15 |
| Feasibility Study Testing Transcriptional Responses as an Indicator of Individualised Responses to Radiation Effects (NCT02780375) | Institute of Cancer Research, United Kingdom | 2016-09-12 |
| Imaging NSCLC Treatment Response to Immunotherapy (NCT02753569) | Institute of Cancer Research, United Kingdom | 2016-05-31 |
| MR-HIFU for Recurrent Gynaecological Cancer (NCT02714621) | Institute of Cancer Research, United Kingdom | 2016-05-01 |
| The BARCODE 1 Pilot Study (NCT03158922) | Institute of Cancer Research, United Kingdom | 2016-04-29 |
| Study of Tumour Focused Radiotherapy for Bladder Cancer (NCT02447549) | Institute of Cancer Research, United Kingdom | 2015-10-21 |
| The GENPET Study - An Imaging Study of FCH-PET-CT in Men With Prostate Cancer and a DNA Repair Gene Mutation. (NCT05097274) | Institute of Cancer Research, United Kingdom | 2015-10-15 |
| Quantification of Breast RadioTherapy Associated Late Toxicity Using Novel UltraSound Techniques (NCT02388230) | Institute of Cancer Research, United Kingdom | 2015-10-01 |
| Evaluation of Clarity Ultrasound Guidance for Prostate Therapy (NCT02388308) | Institute of Cancer Research, United Kingdom | 2015-05-15 |
| Evolution of Resistance to Systemic Therapies in Patients With Breast Cancer (NCT02257775) | Institute of Cancer Research, United Kingdom | 2015-05-11 |
| Imaging in Clinical Trials - a Questionnaire Study to Assess Impact of Imaging Regimes on Patient Participation (NCT02541266) | Institute of Cancer Research, United Kingdom | 2015-04-01 |
| Imageguided Theranostics in Multiple Myeloma (NCT02403102) | Institute of Cancer Research, United Kingdom | 2015-03-26 |
| The PROFILE Study: Germline Genetic Profiling: Correlation With Targeted Prostate Cancer Screening and Treatment (NCT02543905) | Institute of Cancer Research, United Kingdom | 2015-03-09 |
| A Study of Enzalutamide in Combination With AZD5363 in Patients With mCRPC (NCT02525068) | Institute of Cancer Research, United Kingdom | 2014-12-01 |
| Investigating Bladder Chemotherapy Instead of Surgery for Low Risk Bladder Cancer (NCT02070120) | Institute of Cancer Research, United Kingdom | 2014-10-01 |
| Analysing Outcomes After Prostate Cancer Diagnosis and Treatment in Carriers of Rare Germline Mutations (NCT02705846) | Institute of Cancer Research, United Kingdom | 2014-09-01 |
| Study of Weekly Radiotherapy for Bladder Cancer (NCT01810757) | Institute of Cancer Research, United Kingdom | 2014-04-01 |
| A Phase II Trial of Vinflunine Chemotherapy in Locally-advanced and Metastatic Carcinoma of the Penis (VinCaP) (NCT02057913) | Institute of Cancer Research, United Kingdom | 2014-03-17 |
| MR-HIFU for Bone Metastases (NCT01964677) | Institute of Cancer Research, United Kingdom | 2014-01-01 |
| Apparent Diffusion Coefficient as a Prognostic Biomarker in Cervical Cancer (NCT01937533) | Institute of Cancer Research, United Kingdom | 2013-10-02 |
| Lactate Imaging as a Tumour Biomarker (NCT01881386) | Institute of Cancer Research, United Kingdom | 2013-09-01 |
| Preoperative Imaging in Retroperitoneal Sarcoma (NCT01902667) | Institute of Cancer Research, United Kingdom | 2013-07-01 |
| Magnetic Resonance Imaging Screening in Li Fraumeni Syndrome (NCT01737255) | Institute of Cancer Research, United Kingdom | 2012-10-01 |
| A Phase II Study of Axitinib in Patients With Metastatic Renal Cell Cancer Unsuitable for Nephrectomy (NCT01693822) | Institute of Cancer Research, United Kingdom | 2012-10-01 |
| Diffusion-weighted Imaging Study in Cancer of the Ovary (NCT01505829) | Institute of Cancer Research, United Kingdom | 2012-08-01 |
| TOPARP: A Phase II Trial of Olaparib in Patients With Advanced Castration Resistant Prostate Cancer (NCT01682772) | Institute of Cancer Research, United Kingdom | 2012-07-01 |
| A Phase III Randomised Trial of Peri-Operative Chemotherapy Versus sUrveillance in Upper Tract Urothelial Cancer (POUT) (NCT01993979) | Institute of Cancer Research, United Kingdom | 2012-05-01 |
| A Trial of Cediranib in the Treatment of Patients With Alveolar Soft Part Sarcoma (CASPS) (NCT01337401) | Institute of Cancer Research, United Kingdom | 2011-07-01 |
| A Study of Prostate and pelvIs Versus prOsTate Alone Treatment for Locally Advanced Prostate Cancer (NCT01685190) | Institute of Cancer Research, United Kingdom | 2011-06-01 |
| Assessing Treatment Response in Breast Cancer With Functional Imaging (NCT02688257) | Institute of Cancer Research, United Kingdom | 2010-09-01 |
| Trastuzumab or Lapatinib Ditosylate in Treating Women With Early Breast Cancer (NCT01104571) | Institute of Cancer Research, United Kingdom | 2010-04-01 |
| Trial of 1 Cycle of Adjuvant BEP Chemotherapy in High Risk, Stage 1 Non-seminomatous Germ Cell Testis Tumours (NCT01726374) | Institute of Cancer Research, United Kingdom | 2010-02-01 |
| A Trial Looking at Nilotinib to Treat Acral and Mucosal Melanoma Skin Cancer That Has Spread (NCT01395121) | Institute of Cancer Research, United Kingdom | 2009-12-01 |
| 3-Dimensional Conformal Radiation Therapy in Treating Patients With Bladder Cancer Who Have Undergone Transurethral Resection of the Bladder (NCT01124682) | Institute of Cancer Research, United Kingdom | 2009-05-01 |
| Trial of Perioperative Endocrine Therapy - Individualising Care (NCT02338310) | Institute of Cancer Research, United Kingdom | 2008-09-01 |
| Intensity-Modulated Radiation Therapy or 3-Dimensional Conformal Radiation Therapy in Decreasing Hearing Loss in Patients Who Have Undergone Surgery for Parotid Tumors (NCT01216800) | Institute of Cancer Research, United Kingdom | 2008-08-01 |
| Radiation Therapy in Treating Women Who Have Undergone Breast Conservation Surgery and Systemic Therapy for Early Breast Cancer (NCT00818051) | Institute of Cancer Research, United Kingdom | 2008-08-01 |
| Triple Negative Breast Cancer Trial (NCT00532727) | Institute of Cancer Research, United Kingdom | 2008-01-01 |
| MR Characterisation/Localisation of Breast Cancer (NCT01567137) | Institute of Cancer Research, United Kingdom | 2007-11-01 |
| Radiation Therapy or Surgery in Treating Patients Receiving Chemotherapy for Bladder Cancer (NCT00867347) | Institute of Cancer Research, United Kingdom | 2007-07-01 |
| Short-term Presurgical Study to Assess Molecular Predictors of Lapatinib's Effects in Primary Breast Cancer (NCT00299286) | Institute of Cancer Research, United Kingdom | 2007-06-01 |
| Radiation Therapy in Women With Low Risk Early-Stage Breast Cancer Who Have Undergone Breast Conservation Surgery (NCT00814567) | Institute of Cancer Research, United Kingdom | 2007-05-03 |
| Combination Chemotherapy in Treating Patients With Early Stage Breast Cancer That Has Been Removed By Surgery (NCT00301925) | Institute of Cancer Research, United Kingdom | 2005-12-16 |
| 17-Dimethylaminoethylamino-17-Demethoxygeldanamycin (17-DMAG) in Treating Patients With Metastatic Solid Tumors or Tumors That Cannot Be Removed By Surgery (NCT00248521) | Institute of Cancer Research, United Kingdom | 2005-10-01 |
| Combination Chemotherapy With or Without Surgery and Radiation Therapy in Treating Patients With Mesothelioma That Can Be Removed By Surgery (NCT00253409) | Institute of Cancer Research, United Kingdom | 2005-05-01 |
| The IMPACT Study - Identification of Men With a Genetic Predisposition to ProstAte Cancer (NCT00261456) | Institute of Cancer Research, United Kingdom | 2005-03-01 |
| Radiation Therapy in Treating Women With Localized Breast Cancer (NCT00107497) | Institute of Cancer Research, United Kingdom | 2004-10-05 |
| Adjuvant Radiation Therapy Compared With Observation After Surgery in Treating Women With Estrogen Receptor Positive or Progesterone Receptor Positive Ductal Carcinoma In Situ of the Breast Who Are Receiving Tamoxifen or Anastrozole (NCT00077168) | Institute of Cancer Research, United Kingdom | 2004-04-01 |
| Hyperbaric Oxygen Therapy Compared With Standard Therapy in Treating Chronic Arm Lymphedema in Patients Who Have Undergone Radiation Therapy for Cancer (NCT00077090) | Institute of Cancer Research, United Kingdom | 2004-04-01 |